VITAMIN D RESISTANCE AND RELATED DISORDERS
维生素 D 抵抗和相关疾病
基本信息
- 批准号:2573695
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
With the recognition that vitamin D is the precursor for the steroid
hormone, calcitriol, it has become possible to characterize defects in
the target actions of calcitriol. We have demonstrated a broad
spectrum of manifestations of hereditary resistance to calcitriol.
This syndrome usually results from a mutation in the gene for the
vitamin D receptor. Skin fibroblasts from subjects with hereditary
resistance to calcitriol all display abnormalities in this effector
system, and defects in many discrete steps of this pathway have been
identified with these cells. Cells with mutations in the calcitriol
effector pathway can be used to explore mechanisms of calciferol
action. They have been used to establish that the vitamin D receptor
mediates an extremely rapid (within 1-3 min) rise of cyclic GMP in
response to calcitriol and to demonstrate that cGMP plays a role in
receptor translocation. These cells have also been used to show that
certain receptor mutations compromise many receptor functions but
allow another functions to be retained normally. This establishes that
calcitriol receptors couple to different responses by distinct
mechanisms. With the development of a new, pharmacologically relevant
fluorescent calcitriol, it became possible to study vitamin D receptor
activation in living cells and recognize abnormalities in vitamin D
receptor translocation from the cytoplasm to the nucleus. The
fluorescent calcitriol allowed the use of confocal microscopy to
identify the association of vitamin D receptors with endoplasmic
reticulum and microtubules, and to visualize intranuclear target
sites.Transient expression of a green fluorescent protein
glucocorticoid receptor chimeric protein allowed us to study the
activation of another steroid receptor in real-time by microscopy, and
allowed the generalization of our findings on vitamin D receptor
activation process.
认识到维生素D是类固醇的前体
激素,骨化三醇,它已经有可能表征缺陷的
骨化三醇的靶向作用。我们已经展示了一个广泛的
骨化三醇遗传性抵抗的表现谱。
这种综合征通常是由于基因突变引起的
维生素D受体。遗传性疾病患者的皮肤成纤维细胞
对骨化三醇的抵抗在这个效应器中都表现出异常。
这条途径的许多离散步骤中的缺陷已经被
与这些细胞相一致。骨化三醇基因突变的细胞
效应通路可用于探讨骨化醇的作用机制
行动。它们已被用来确定维生素D受体
在1-3分钟内调节循环GMP的极快速升高
对骨化三醇的反应,并证明cGMP在
受体易位。这些细胞也被用来证明
某些受体突变损害了许多受体功能,但
允许其他功能正常保留。这就确立了
骨化三醇受体通过不同的方式偶联到不同的反应
机制。随着一种新的、药理上相关的
荧光骨化三醇使研究维生素D受体成为可能
活细胞的激活与维生素D的异常识别
受体从细胞质转位到细胞核。这个
荧光骨化三醇使共聚焦显微镜的使用
确定维生素D受体与内质的关系
网状和微管,并显示核内靶点
一种绿色荧光蛋白的瞬时表达
糖皮质激素受体嵌合蛋白使我们能够研究
通过显微镜实时激活另一种类固醇受体,以及
允许对我们关于维生素D受体的发现进行推广
激活过程。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
J BARSONY其他文献
J BARSONY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('J BARSONY', 18)}}的其他基金
相似海外基金
FAIRClinical: FAIR-ification of Supplementary Data to Support Clinical Research
FAIRClinical:补充数据的 FAIR 化以支持临床研究
- 批准号:
EP/Y036395/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Research Grant
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
- 批准号:
10764456 - 财政年份:2023
- 资助金额:
-- - 项目类别:
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
- 批准号:
10715568 - 财政年份:2023
- 资助金额:
-- - 项目类别:
The Mayo Clinic NeuroNEXT Clinical Research Site
梅奥诊所 NeuroNEXT 临床研究网站
- 批准号:
10743328 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint
解决临床试验注册表现不佳的问题:开发临床试验工具包并扩大临床研究足迹
- 批准号:
10638813 - 财政年份:2023
- 资助金额:
-- - 项目类别:
The Minnesota TMD IMPACT Collaborative: Integrating Basic/Clinical Research Efforts and Training to Improve Clinical Care
明尼苏达州 TMD IMPACT 协作:整合基础/临床研究工作和培训以改善临床护理
- 批准号:
10828665 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Improving Multicultural Engagement in Clinical Research through Partnership with Federally Qualified Health Centers and Community Health Worker Programs
通过与联邦合格的健康中心和社区卫生工作者计划合作,改善临床研究中的多元文化参与
- 批准号:
10823828 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.
在 NCI 资助的临床研究中促进创新、指导、多样性和机会文化:Janice M. Mehnert 医学博士的 NCI 研究专家(临床科学家)奖申请
- 批准号:
10721095 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Clinical Research Center for REstoration of NEural-based Function in the Real World (RENEW)
现实世界神经功能恢复临床研究中心 (RENEW)
- 批准号:
10795328 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Mentoring Scientists for Careers in HIV Translational Clinical Research
指导科学家从事艾滋病毒转化临床研究
- 批准号:
10762827 - 财政年份:2023
- 资助金额:
-- - 项目类别:














{{item.name}}会员




